“Above the Bias” Aims to Reduce Misconceptions & Shame
Abbott (NYSE: ABT) unveiled “Above the Bias,” a global initiative addressing diabetes-related stigma.
Key Findings from a Global Survey:
- 70% of people with diabetes report experiencing stigma.
- 85% see misinformation in media about diabetes.
- 40% have skipped doctor visits due to shame.
- The phrase “Should you really be eating that?” triggers the strongest stress response.
Abbott’s Mission:
- Raise awareness of diabetes-related biases.
- Encourage support to improve patient motivation.
- Partner with advocacy groups to change perceptions.
🔗 Learn more at AboveBias.com
Follow MEDWIRE.AI for more updates on diabetes innovation.
